NCT06746896View on ClinicalTrials.gov

Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis

Active, not recruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

November 24, 2022

Study Completion Date

September 30, 2025

Conditions

Multiple Sclerosis

Trial Locations (1)

20132

IRCCS San Raffaele, Milan

All Listed Sponsors

collaborator

Università Vita-Salute San Raffaele

OTHER

lead

Prof. Massimo Filippi

OTHER